Evidence map›Paper›PMID 33917983›Full record

ArticleBiomolecules2021

Liquid-Liquid Phase Separation Enhances TDP-43 LCD Aggregation but Delays Seeded Aggregation.

Donya Pakravan, Emiel Michiels, Anna Bratek-Skicki, Mathias De Decker, Joris Van Lindt, David Alsteens, Sylvie Derclaye, Philip Van Damme, Joost Schymkowitz, Frederic Rousseau and 2 more

Open access · goldAbstract read
In one paragraph

Article in Biomolecules, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 50 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. [Mechanisms of RNA-binding protein phase separation in steroid-associated necrosis of the femoral head].Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences · 2026
    Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Donya PakravanDepartment of Neurosciences, Experimental Neurology and Leuven Brain Institute (LBI), KU Leuven-University of Leuven, 3000 Leuven, Belgium.ORCID 0000-0002-3165-984X
Emiel MichielsSwitch Laboratory, VIB-KU Leuven Center for Brain & Disease Research, 3000 Leuven, Belgium.ORCID 0000-0001-6065-5576
Anna Bratek-SkickiVIB-VUB Center for Structural Biology, 1050 Brussels, Belgium.
Mathias De DeckerDepartment of Neurosciences, Experimental Neurology and Leuven Brain Institute (LBI), KU Leuven-University of Leuven, 3000 Leuven, Belgium.
Joris Van LindtVIB-VUB Center for Structural Biology, 1050 Brussels, Belgium.
David AlsteensInstitute of Life Sciences, Université Catholique de Louvain, 1348 Louvain-la-Neuve, Belgium.ORCID 0000-0001-9229-113X
Sylvie DerclayeInstitute of Life Sciences, Université Catholique de Louvain, 1348 Louvain-la-Neuve, Belgium.
Philip Van DammeDepartment of Neurosciences, Experimental Neurology and Leuven Brain Institute (LBI), KU Leuven-University of Leuven, 3000 Leuven, Belgium.
Joost SchymkowitzSwitch Laboratory, VIB-KU Leuven Center for Brain & Disease Research, 3000 Leuven, Belgium.ORCID 0000-0003-2020-0168
Frederic RousseauSwitch Laboratory, VIB-KU Leuven Center for Brain & Disease Research, 3000 Leuven, Belgium.
Peter TompaVIB-VUB Center for Structural Biology, 1050 Brussels, Belgium.ORCID 0000-0001-8042-9939
Ludo Van Den BoschDepartment of Neurosciences, Experimental Neurology and Leuven Brain Institute (LBI), KU Leuven-University of Leuven, 3000 Leuven, Belgium.ORCID 0000-0003-0104-4067
VIB-KU Leuven Center for Brain & Disease Research · BEVIB-VUB Center for Structural Biology · BEUCLouvain · BE

Funding

Vlaams Instituut voor Biotechnologie International VIB PhD
6 · The paper itself

Abstract

Aggregates of TAR DNA-binding protein (TDP-43) are a hallmark of several neurodegenerative disorders, including amyotrophic lateral sclerosis (ALS). Although TDP-43 aggregates are an undisputed pathological species at the end stage of these diseases, the molecular changes underlying the initiation of aggregation are not fully understood. The aim of this study was to investigate how phase separation affects self-aggregation and aggregation seeded by pre-formed aggregates of either the low-complexity domain (LCD) or its short aggregation-promoting regions (APRs). By systematically varying the physicochemical conditions, we observed that liquid-liquid phase separation (LLPS) promotes spontaneous aggregation. However, we noticed less efficient seeded aggregation in phase separating conditions. By analyzing a broad range of conditions using the Hofmeister series of buffers, we confirmed that stabilizing hydrophobic interactions prevail over destabilizing electrostatic forces. RNA affected the cooperativity between LLPS and aggregation in a "reentrant" fashion, having the strongest positive effect at intermediate concentrations. Altogether, we conclude that conditions which favor LLPS enhance the subsequent aggregation of the TDP-43 LCD with complex dependence, but also negatively affect seeding kinetics.

Indexed as

Liquid-Liquid ExtractionProtein AggregatesAmyotrophic Lateral SclerosisDNA-Binding ProteinsFluorescence Recovery After PhotobleachingHumansHydrophobic and Hydrophilic InteractionsPeptidesProtein DomainsRecombinant ProteinsRNAStatic ElectricityDNA-Binding ProteinsPeptidesProtein AggregatesRecombinant ProteinsRNATARDBP protein, humanaggregationamyotrophic lateral sclerosisphase separationTDP-43

Identifiers

PMID33917983
PMCPMC8068378
OpenAlexW3139694296

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.